Mathias Romacker is an independent device strategy consultant. He has also served as a Kymanox Executive Advisor (KEA) since 2022.
Mr Romacker has than 30 years of experience in the field of injectable drug delivery devices. He brings a deep understanding of prefilled syringes, handheld injection devices and on-body wearable devices, having been involved in multiple successful combination product launches.
He was Senior Director, Device Strategy at Pfizer Headquarters in New York City, until late 2019 having joined the company in March 2015. In this commercial role he focused on the front end of device technology. He worked with multiple functions and sites across the organisation to develop a device strategy for Pfizer pipeline and inline products. Previously he worked for more than nine years in the device area for Amgen. Before joining Amgen he held multiple sales and marketing positions with BD and Gerresheimer in Germany, South Africa and New Jersey, US.
Mr Romacker was a co-chair for the PDA Universe of Pre-filled Syringes and Injection Devices in 2013, 2017, 2019 and 2022, and received the PDA Edward Smith Packaging Science Award in 2018 for his contributions over the years. He holds a Masters equivalent degree in Economics from the University of Freiburg, Germany.